September 08, 2021
Article
A neighborhood-level assessment of major cities show areas impacted the most by historic COVID-19 deaths are significantly less vaccinated.
August 31, 2021
New Imbokodo findings show a 4-dose regimen was only about 25% effective in preventing HIV in at-risk women, hindering progress for the vaccine.
August 26, 2021
An Israel study estimates vaccinated persons' risk of side effects including myocarditis, relative to the risk brought on by SARS-CoV-2 infection.
August 25, 2021
The submission comes day after BNT162b2 became the first fully approved COVID-19 vaccine by the FDA.
August 23, 2021
The full approval for BNT162b2 will afford physicians greater prescribing capability, and will likely drive workplace vaccine mandates.
August 17, 2021
The Biden administration reportedly hopes for FDA-authorized booster doses for the adult general population in the next month.
August 16, 2021
The US is targeting a possible Fall rollout of publicly available doses, yet experts debate their current necessity.
August 13, 2021
Donald Alcendor, PhD, shares expert perspective on the newest FDA authorization, as well as what a full COVID-19 vaccine approval would mean for US immunization.
The move will offer an extra boost of immunity for patients with compromised immune systems, including organ transplant recipients.
August 12, 2021
An England study shows the Pfizer-BioNTech and AstraZeneca vaccines remain effective in reducing symptomatic disease risk.
